Wright Medical Group N.V. Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance

Go back to Wright Medical Group N.V. Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance

Leerink Partners Cuts Price Target on Wright Medical Group (WMGI) Following 3Q

November 3, 2016 7:22 AM EDT

Leerink Partners maintained an Outperform rating on Wright Medical Group (NASDAQ: WMGI), and cut the price target to $25.00 (from $27.00), following the company's 3Q earnings report. Revenue from continuing operations of $157.3M was about in-line with consensus' $157.7M. EBITDA of $5.7M beat the consensus estimate of... More

Wright Medical Group (WMGI) Tops Q3 EPS by 1c, Offers FY Guidance

November 2, 2016 4:18 PM EDT

Wright Medical Group (NASDAQ: WMGI) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $157.3 million versus the consensus estimate of $157.81 million.

GUIDANCE:

Wright Medical Group sees FY2016 EPS of ($0.47)-($0.52), versus the... More